サマリー

レッドバイオテクノロジーの世界市場 2024-2028
赤色バイオテクノロジー市場は2023〜2028年に1,745億6,000万米ドル成長し、予測期間中のCAGRは6.23%で加速すると予測されています。この調査レポートは、レッドバイオテクノロジー市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、ゲノム研究の進展、慢性疾患の有病率の増加、世界的な高齢化の進展などが牽引しています。
Technavio社の赤色バイオテクノロジー市場は以下のように分類されます：
製品別
- モノクローナル抗体
- 遺伝子治療
- ポリクローナル抗体
- 細胞ベースの免疫療法製品
- その他
エンドユーザー別
- 製薬会社およびバイオテクノロジー企業
- CMOおよびCRO
- 学術研究機関
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、幹細胞研究と治療の増加が、今後数年間の赤色バイオテクノロジー市場の成長を促進する主要な理由の1つであると特定している。また、バイオ医薬品や治療用タンパク質の生産の増加、バイオインフォマティクスやデータ分析の普及の高まりは、市場の大きな需要につながる。
この調査レポートは、レッドバイオテクノロジー市場を調査・分析し、以下のてこ入れを行います：
- レッドバイオテクノロジー市場のサイジング
- レッドバイオテクノロジー市場の予測
- レッドバイオテクノロジー市場の産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上できるように設計されています。これに伴い、本レポートでは、Amgen Inc.、Astellas Pharma Inc.、AstraZeneca Plc、Bayer AG、Biogen Inc.、Boehringer Ingelheim International GmbH、Bristol Myers Squibb Co、Bruker Corp.、CRISPR Therapeutics AG、Editas Medicine Inc.、F. Hoffmann La Roche Ltd.、Gilead Sciences Inc.、Merck KGaA、Mesoblast Ltd.、Moderna Inc.、Novartis AG、Pfizer Inc.、Regeneron Pharmaceuticals Inc.、STEMCELL Technologies Inc.、Teva Pharmaceutical Industries Ltd.。また、レッドバイオテクノロジー市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、包括的な市場およびベンダーの状況と主要ベンダーの分析が含まれています。本レポートの詳細については、https://www.technavio.com/report/red-biotechnology-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータを分析することにより、複数の情報源からのデータを調査、統合、集計し、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global red biotechnology market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global red biotechnology market 2018 - 2022 ($ billion)
o 4.2 Product Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
o 4.3 End-user Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Monoclonal antibodies - Market size and forecast 2023-2028
o Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
o 6.4 Gene therapy - Market size and forecast 2023-2028
o Exhibit 38: Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
o 6.5 Polyclonal antibodies - Market size and forecast 2023-2028
o Exhibit 42: Chart on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
o 6.6 Cell-based immunotherapy products - Market size and forecast 2023-2028
o Exhibit 46: Chart on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
o 6.7 Others - Market size and forecast 2023-2028
o Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.8 Market opportunity by Product
o Exhibit 54: Market opportunity by Product ($ billion)
o Exhibit 55: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 56: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 57: Data Table on End-user - Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 58: Chart on Comparison by End-user
o Exhibit 59: Data Table on Comparison by End-user
o 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
o Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
o 7.4 CMOs and CROs - Market size and forecast 2023-2028
o Exhibit 64: Chart on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on CMOs and CROs - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on CMOs and CROs - Year-over-year growth 2023-2028 (%)
o 7.5 Academic research institutes - Market size and forecast 2023-2028
o Exhibit 68: Chart on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Data Table on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
o Exhibit 70: Chart on Academic research institutes - Year-over-year growth 2023-2028 (%)
o Exhibit 71: Data Table on Academic research institutes - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by End-user
o Exhibit 72: Market opportunity by End-user ($ billion)
o Exhibit 73: Data Table on Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 China - Market size and forecast 2023-2028
o Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.9 UK - Market size and forecast 2023-2028
o Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 Germany - Market size and forecast 2023-2028
o Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 123: Amgen Inc. - Overview
o Exhibit 124: Amgen Inc. - Product / Service
o Exhibit 125: Amgen Inc. - Key offerings
o 12.4 Astellas Pharma Inc.
o Exhibit 126: Astellas Pharma Inc. - Overview
o Exhibit 127: Astellas Pharma Inc. - Product / Service
o Exhibit 128: Astellas Pharma Inc. - Key news
o Exhibit 129: Astellas Pharma Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 130: AstraZeneca Plc - Overview
o Exhibit 131: AstraZeneca Plc - Product / Service
o Exhibit 132: AstraZeneca Plc - Key news
o Exhibit 133: AstraZeneca Plc - Key offerings
o 12.6 Bayer AG
o Exhibit 134: Bayer AG - Overview
o Exhibit 135: Bayer AG - Business segments
o Exhibit 136: Bayer AG - Key news
o Exhibit 137: Bayer AG - Key offerings
o Exhibit 138: Bayer AG - Segment focus
o 12.7 Biogen Inc.
o Exhibit 139: Biogen Inc. - Overview
o Exhibit 140: Biogen Inc. - Product / Service
o Exhibit 141: Biogen Inc. - Key offerings
o 12.8 Boehringer Ingelheim International GmbH
o Exhibit 142: Boehringer Ingelheim International GmbH - Overview
o Exhibit 143: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 144: Boehringer Ingelheim International GmbH - Key news
o Exhibit 145: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 146: Boehringer Ingelheim International GmbH - Segment focus
o 12.9 Bristol Myers Squibb Co.
o Exhibit 147: Bristol Myers Squibb Co. - Overview
o Exhibit 148: Bristol Myers Squibb Co. - Product / Service
o Exhibit 149: Bristol Myers Squibb Co. - Key news
o Exhibit 150: Bristol Myers Squibb Co. - Key offerings
o 12.10 Bruker Corp.
o Exhibit 151: Bruker Corp. - Overview
o Exhibit 152: Bruker Corp. - Business segments
o Exhibit 153: Bruker Corp. - Key news
o Exhibit 154: Bruker Corp. - Key offerings
o Exhibit 155: Bruker Corp. - Segment focus
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
o 12.12 Gilead Sciences Inc.
o Exhibit 161: Gilead Sciences Inc. - Overview
o Exhibit 162: Gilead Sciences Inc. - Product / Service
o Exhibit 163: Gilead Sciences Inc. - Key news
o Exhibit 164: Gilead Sciences Inc. - Key offerings
o 12.13 Merck KGaA
o Exhibit 165: Merck KGaA - Overview
o Exhibit 166: Merck KGaA - Business segments
o Exhibit 167: Merck KGaA - Key news
o Exhibit 168: Merck KGaA - Key offerings
o Exhibit 169: Merck KGaA - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 170: Pfizer Inc. - Overview
o Exhibit 171: Pfizer Inc. - Product / Service
o Exhibit 172: Pfizer Inc. - Key news
o Exhibit 173: Pfizer Inc. - Key offerings
o 12.15 Regeneron Pharmaceuticals Inc.
o Exhibit 174: Regeneron Pharmaceuticals Inc. - Overview
o Exhibit 175: Regeneron Pharmaceuticals Inc. - Product / Service
o Exhibit 176: Regeneron Pharmaceuticals Inc. - Key offerings
o 12.16 STEMCELL Technologies Inc.
o Exhibit 177: STEMCELL Technologies Inc. - Overview
o Exhibit 178: STEMCELL Technologies Inc. - Product / Service
o Exhibit 179: STEMCELL Technologies Inc. - Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 180: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 181: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 183: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 184: Teva Pharmaceutical Industries Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 185: Inclusions checklist
o Exhibit 186: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 187: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 188: Research methodology
o Exhibit 189: Validation techniques employed for market sizing
o Exhibit 190: Information sources
o 13.5 List of abbreviations
o Exhibit 191: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global red biotechnology market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Product ($ billion)
Exhibits55: Data Table on Market opportunity by Product ($ billion)
Exhibits56: Chart on End-user - Market share 2023-2028 (%)
Exhibits57: Data Table on End-user - Market share 2023-2028 (%)
Exhibits58: Chart on Comparison by End-user
Exhibits59: Data Table on Comparison by End-user
Exhibits60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on CMOs and CROs - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on CMOs and CROs - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Academic research institutes - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Academic research institutes - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by End-user ($ billion)
Exhibits73: Data Table on Market opportunity by End-user ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Amgen Inc. - Overview
Exhibits124: Amgen Inc. - Product / Service
Exhibits125: Amgen Inc. - Key offerings
Exhibits126: Astellas Pharma Inc. - Overview
Exhibits127: Astellas Pharma Inc. - Product / Service
Exhibits128: Astellas Pharma Inc. - Key news
Exhibits129: Astellas Pharma Inc. - Key offerings
Exhibits130: AstraZeneca Plc - Overview
Exhibits131: AstraZeneca Plc - Product / Service
Exhibits132: AstraZeneca Plc - Key news
Exhibits133: AstraZeneca Plc - Key offerings
Exhibits134: Bayer AG - Overview
Exhibits135: Bayer AG - Business segments
Exhibits136: Bayer AG - Key news
Exhibits137: Bayer AG - Key offerings
Exhibits138: Bayer AG - Segment focus
Exhibits139: Biogen Inc. - Overview
Exhibits140: Biogen Inc. - Product / Service
Exhibits141: Biogen Inc. - Key offerings
Exhibits142: Boehringer Ingelheim International GmbH - Overview
Exhibits143: Boehringer Ingelheim International GmbH - Business segments
Exhibits144: Boehringer Ingelheim International GmbH - Key news
Exhibits145: Boehringer Ingelheim International GmbH - Key offerings
Exhibits146: Boehringer Ingelheim International GmbH - Segment focus
Exhibits147: Bristol Myers Squibb Co. - Overview
Exhibits148: Bristol Myers Squibb Co. - Product / Service
Exhibits149: Bristol Myers Squibb Co. - Key news
Exhibits150: Bristol Myers Squibb Co. - Key offerings
Exhibits151: Bruker Corp. - Overview
Exhibits152: Bruker Corp. - Business segments
Exhibits153: Bruker Corp. - Key news
Exhibits154: Bruker Corp. - Key offerings
Exhibits155: Bruker Corp. - Segment focus
Exhibits156: F. Hoffmann La Roche Ltd. - Overview
Exhibits157: F. Hoffmann La Roche Ltd. - Business segments
Exhibits158: F. Hoffmann La Roche Ltd. - Key news
Exhibits159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits160: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits161: Gilead Sciences Inc. - Overview
Exhibits162: Gilead Sciences Inc. - Product / Service
Exhibits163: Gilead Sciences Inc. - Key news
Exhibits164: Gilead Sciences Inc. - Key offerings
Exhibits165: Merck KGaA - Overview
Exhibits166: Merck KGaA - Business segments
Exhibits167: Merck KGaA - Key news
Exhibits168: Merck KGaA - Key offerings
Exhibits169: Merck KGaA - Segment focus
Exhibits170: Pfizer Inc. - Overview
Exhibits171: Pfizer Inc. - Product / Service
Exhibits172: Pfizer Inc. - Key news
Exhibits173: Pfizer Inc. - Key offerings
Exhibits174: Regeneron Pharmaceuticals Inc. - Overview
Exhibits175: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits176: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits177: STEMCELL Technologies Inc. - Overview
Exhibits178: STEMCELL Technologies Inc. - Product / Service
Exhibits179: STEMCELL Technologies Inc. - Key offerings
Exhibits180: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits181: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits182: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits183: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits184: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations